Daniel Woolson - Mar 6, 2022 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
VP, GM-Infusion Capital
Signature
By: Paula Darbyshire, Attorney-in-fact For: Daniel Woolson
Stock symbol
ICUI
Transactions as of
Mar 6, 2022
Transactions value $
-$155,232
Form type
4
Date filed
3/8/2022, 06:23 PM
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 +1.44K +17.69% $0.00 9.61K Mar 6, 2022 Direct F1
transaction ICUI Common Stock Tax liability -$155K -639 -6.65% $242.93 8.97K Mar 6, 2022 Direct
transaction ICUI Common Stock Options Exercise $0 +1.42K +15.81% $0.00 10.4K Mar 6, 2022 Direct F1
transaction ICUI Common Stock Tax liability $0 -628 -6.05% $0.00 9.76K Mar 6, 2022 Direct F2
transaction ICUI Common Stock Options Exercise $0 +2.02K +20.7% $0.00 11.8K Mar 8, 2022 Direct F1
transaction ICUI Common Stock Tax liability $0 -894 -7.59% $0.00 10.9K Mar 8, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Common Stock Award $0 +2.9K $0.00 2.9K Mar 7, 2022 Common Stock 2.9K $0.00 Direct F2, F3, F4, F5
transaction ICUI Common Stock Options Exercise $0 -1.44K -100% $0.00* 0 Mar 6, 2022 Common Stock 1.44K Direct F1, F6, F7
transaction ICUI Performance Shares Options Exercise $0 -2.02K -33.33% $0.00 4.04K Mar 8, 2022 Common Stock 2.02K $0.00 Direct F1, F6, F8
transaction ICUI Performance Shares Options Exercise $0 -1.42K -50.02% $0.00 1.42K Mar 6, 2022 Common Stock 1.42K Direct F1, F6, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Securities are Performance-based Restricted Stock Units (PRSU).
F2 These securities are Restricted Stock Units.
F3 There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F4 One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F5 These are restricted stock units that fully vest 3 years from the grant date.
F6 There is neither a purchase price nor an exercise price for the PRSUs.
F7 These PRSUs were granted on March 6, 2019. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.
F8 These PRSUs were granted on March 6, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.
F9 These PRSUs were granted on March 6, 2020. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.